# Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases

> **NCT02336763** · NA · TERMINATED · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 2 (actual)

## Conditions studied

- Iris Melanoma
- Medium/Large Size Posterior Uveal Melanoma
- Stage IIA Uveal Melanoma
- Stage IIB Uveal Melanoma
- Stage IIIA Uveal Melanoma
- Stage IIIB Uveal Melanoma
- Stage IIIC Uveal Melanoma

## Interventions

- **RADIATION:** External Beam Radiation Therapy
- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT02336763
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Closed due to lack of accrual
- **Last updated:** 2020-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02336763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02336763, "Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02336763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*